Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 14;12(1):12014.
doi: 10.1038/s41598-022-16113-6.

COVID-19 increases the risk for the onset of atrial fibrillation in hospitalized patients

Affiliations

COVID-19 increases the risk for the onset of atrial fibrillation in hospitalized patients

Jakob Wollborn et al. Sci Rep. .

Abstract

COVID-19 is associated with significant extrapulmonary symptoms. Myocardial involvement has been described for infections with SARS-CoV-2 which may lead to an increase in morbidity and mortality. The objective of our study was to investigate the association of COVID-19 and atrial fibrillation (AF) or atrial flutter (AFl) in hospitalized patients. This retrospective study used electronic medical records to detect patients with COVID-19 and their comorbidities within the Mass General Brigham hospital system. All patients ≥ 18 years who were hospitalized and received a PCR test for SARS-CoV-2 were screened for inclusion as well as patients from a pre-pandemic cohort. We matched on common risk factors for AF and then used multivariable logistic regression to estimate the odds for AF or AFl. Of 78,725 patients eligible for analysis, 11,004 COVID-19 negative patients were matched to 3,090 COVID-19 positive patients and 5005 pre-pandemic patients were matched to 2283 COVID-19 positive patients. After adjusting for demographics and comorbidities, COVID-19 positive patients had 1.19 times the odds (95% CI 1.00, 1.41) of developing AF compared to COVID-19 negative patients and 1.57 times the odds (95% CI 1.23, 2.00) of developing AF compared to pre-pandemic patients. Our study demonstrated an increased risk for AF, directing the attention for improved screening and treatment regimens for the sequelae of COVID-19. While COVID-19 continues to affect many people around the world, AF may be a significant cause for morbidity and mortality. Adequate detection and treatment of AF is essential to reduce the burden of disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Patient selection and study flow chart.
Figure 2
Figure 2
Multivariable logistic regression model and forest plots to determine the risk for atrial fibrillation after matching (blank rows due to insufficient data to analyze the variables Hispanic vs. White and History of myocardial infarction; “Race: Other vs White” includes Hispanic for the COVID-19 positive vs. Pre-Pandemic model; AF atrial fibrillation, AFl atrial flutter, COPD chronic obstructive pulmonary disease).
Figure 3
Figure 3
Summarizing figure of the study’s findings.

References

    1. Libby P. The heart in COVID-19. JACC. Basic Transl. Sci. 2020;5:537–542. doi: 10.1016/j.jacbts.2020.04.001. - DOI - PMC - PubMed
    1. Pérez-Bermejo JA, et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients. Biorxiv. 2020 doi: 10.1101/2020.08.25.265561. - DOI - PMC - PubMed
    1. Rajpal, S. et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. vol. 6 (2021). - PMC - PubMed
    1. Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. vol. 5 (2020). - PMC - PubMed
    1. Boos CJ. Infection and atrial fibrillation: Inflammation begets AF. Eur. Heart J. 2020;41:1120–1122. doi: 10.1093/eurheartj/ehz953. - DOI - PubMed

Publication types